CTT Pharmaceutical Holdings, Inc. announced that the Company is pivoting to a more aggressive business development model targeting new industry verticals and geographic jurisdictions. To this end, the Company has strengthened its team with the appointment of Mr. Ryan Khouri and Dr. Greg Fedorcik as Director of Nutraceuticals and Director of Pharmaceuticals, respectively. Both Mr. Khouri and Dr. Fedorcik will report to Marc Lakmaaker. Mr. Lakmaaker, previously appointed as special advisor to the Company, will take on additional responsibility as SVP Commercial Development at CTT. Mr. Lakmaaker, a chemical engineer and former Aurora Cannabis executive, has been active in the cannabis sector for over 5 years in a variety of roles. He brings a solid track record in business development, including leading a sales team in the specialty chemicals sector. Mr. Lakmaaker founded Clearview Capital Consult, a strategy, IR and communications advisory in 2019, and has since helped various companies in the sector with a variety of corporate initiatives, such as strategic development, turnarounds, commercialization, capitalization and communications. Mr. Khouri is a consummate salesman who started his first company in his early twenties, which he developed into a multi-million dollar sales engine. He has an extensive history in sales and investments in the United States and has a deep network of corporate connections that he will leverage to expand CTT's commercial reach into the nutraceutical industry.